Compliance-Heavy Sectors
Regulated & Compliance-Heavy Sectors
In health, medical equipment, and certification-dependent sectors, regulatory timeline is the constraint that determines entry feasibility. A company can have a viable product, a commercial model, and a qualified distributor, and still find that the certification sequence will take 18 to 36 months.
Entry Challenge
Discovering regulatory timeline constraints after committing to an entry plan is expensive. The specific failure pattern in this sector is: company commits to a commercial timeline, appoints a distributor, and then discovers the regulatory process will not complete in time to meet the commercial commitments made. The validation stage for regulated sectors exists specifically to map the regulatory timeline before any commercial commitment is made.
What We Validate
Regulatory pathway: which directives apply, which notified body or authority is involved, and what the realistic timeline is for each stage. Market access structure: whether the product reaches buyers through clinical procurement, distributor networks, or direct specification. Buyer decision process: whether the purchase decision is made by procurement, clinical staff, or both.
What an Engagement Looks Like
Stage 1 maps the full regulatory pathway and produces a realistic timeline with decision points. Stage 2 identifies qualified distribution or market access channels that operate in the post-regulation market structure. Stage 3 structures the entry plan around the regulatory timeline. Stage 4 oversees execution from certification milestone to first commercial engagement.
Most Common Obstacle
Companies approach distribution before completing regulatory validation. Distributors in these sectors will not take on an unregulated product because they carry liability for market access. A company with a product that cannot yet be sold and a distributor that cannot help. The resolution requires mapping the regulatory sequence before approaching distribution.
Regulated & Compliance-Heavy Sectors
In health, medical equipment, and certification-dependent sectors, regulatory timeline is the constraint that determines entry feasibility. A company can have a viable product, a commercial model, and a qualified distributor, and still find that the certification sequence will take 18 to 36 months.
Entry Challenge
Discovering regulatory timeline constraints after committing to an entry plan is expensive. The specific failure pattern in this sector is: company commits to a commercial timeline, appoints a distributor, and then discovers the regulatory process will not complete in time to meet the commercial commitments made. The validation stage for regulated sectors exists specifically to map the regulatory timeline before any commercial commitment is made.
What We Validate
Regulatory pathway: which directives apply, which notified body or authority is involved, and what the realistic timeline is for each stage. Market access structure: whether the product reaches buyers through clinical procurement, distributor networks, or direct specification. Buyer decision process: whether the purchase decision is made by procurement, clinical staff, or both.
Most Common Obstacle
Companies approach distribution before completing regulatory validation. Distributors in these sectors will not take on an unregulated product because they carry liability for market access. A company with a product that cannot yet be sold and a distributor that cannot help. The resolution requires mapping the regulatory sequence before approaching distribution.
What an Engagement Looks Like
Stage 1 maps the full regulatory pathway and produces a realistic timeline with decision points. Stage 2 identifies qualified distribution or market access channels that operate in the post-regulation market structure. Stage 3 structures the entry plan around the regulatory timeline. Stage 4 oversees execution from certification milestone to first commercial engagement.